News Pharma Industry

KIMS Hospitals aced value pricing. New growth will hinge on navigating pandemic and expansion costs.

[ad_1]

KIMS Hospitals aced value pricing. New growth will hinge on navigating pandemic and expansion costs.

A hospital staff (L) poses for pictures after getting a Covid-19 vaccine at the KIMS hospital in Hyderabad.

Synopsis

While the company’s financial performance has been robust and it has a healthy balance sheet, sustaining growth rates and profitability could be a challenge, given the uncertainties related to Covid-19 and higher capital expenditure likely in the next three to five years.

Thanks to the bull run in stock markets, 2021 has been an action-packed year for initial public offerings (IPOs). Last week, the INR2,144 crore IPO of Krishna Institute of Medical Sciences (KIMS Hospitals) was subscribed 3.9 times. The IPO of the Hyderabad-based company has come at a time when healthcare is in the forefront due to the Covid-19 pandemic and hospital stocks have surged in the last one year. Investors’ interest in pharmaceutical

  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Special Offer on ET Prime

Subscribe to ET Prime – Get Flat 20% Off

View Plans

Special Offer on ET Prime

Subscribe to ET Prime – Get Flat 25% Off

View Plans

Special Offer on ET Prime

Subscribe to ET Prime – Get Flat 25% Off

View Plans

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

[ad_2]

Source link